Assay to detect viral uncoating
A cell-free viral uncoating assay is provided.
1. A cell-free method for release of viral cores of enveloped viruses from endosomes, comprising:
a) providing a cell-free sample comprising intact endosomes comprising fusion arrested enveloped viral particles, which endosomes are isolated from cells that express one or more viral receptors including the viral receptor TVA and are infected with a pseudotyped enveloped virus having a subgroup A ASLV envelope protein, wherein the endosomes are isolated in the presence of an amount of a lysosomotropic agent that elevates endosomal pH effective to arrest membrane fusion; and
b) subjecting the sample to conditions that allow for virus particle-endosomal membrane fusion and release of viral cores from endosomes, yielding a composition.
2. The method of claim 1 further comprising detecting or determining viral uncoating or viral nucleic acid replication in the composition.
3. The method of claim 1 wherein the pseudotyped virus comprises rhabdovirus, orthomyxovirus, paramyxovirus, retrovirus, lentivirus, bunyavirus, arenavirus, hepadnavirus, flavivirus, coronavirus, or filovirus cores.
4. The method of claim 1 wherein the virus is a retrovirus or lentivirus.
5. The method of claim 1 wherein the cells are recombinant cells.
6. The method of claim 1 wherein the cells are mammalian cells.
7. The method of claim 1 or 2 further comprising contacting the sample with one or more agents and detecting or determining whether the one or more agents alter post-fusion viral uncoating or nucleic acid replication.
8. The method of claim 1 wherein prior to isolating endosomes the cells are contacted with one or more agents.
9. The method of claim 8 further comprising detecting or determining whether the one or more agents alter post-fusion viral uncoating or nucleic acid replication.
10. The method of claim 7 wherein the one or more agents inhibit or block viral uncoating.
11. The method of claim 7 wherein the viral core is a HIV core and wherein the one or more agents inhibit or block HIV-1 uncoating.
12. The method of claim 2 further comprising identifying one or more cellular factors that modulate post-fusion viral uncoating or nucleic acid replication.
13. The method of claim 1 further comprising identifying one or more cellular factors that alter Lv-1 restriction.
14. The method of claim 2 further comprising contacting the composition with one or more agents and detecting or determining whether the one or more agents alter viral uncoating or nucleic acid replication.
15. The method of claim 1 wherein about 70% of the endosomes in the sample are intact.
16. A method to prepare a cell-free sample comprising isolated endosomes having fusion arrested enveloped viral particles, comprising:
a) infecting cells that express one or more viral receptors including the viral receptor TVA with a pseudotyped enveloped virus having a subgroup A ASLV envelope protein in the presence of an amount of a lysosomotropic agent that elevates endosomal pH effective to arrest membrane fusion; and
b) isolating endosomes from the infected cells.